Cypherpunk Technologies (CYPH) Projected to Post Earnings on Wednesday

Cypherpunk Technologies (NASDAQ:CYPH) is expected to be announcing its results before the market opens on Wednesday, March 25th. Analysts expect the company to announce earnings of ($0.20) per share for the quarter.

Cypherpunk Technologies (NASDAQ:CYPH) last announced its earnings results on Monday, March 16th. The company reported $0.92 earnings per share (EPS) for the quarter. On average, analysts expect Cypherpunk Technologies to post $-2 EPS for the current fiscal year and $-1 EPS for the next fiscal year.

Cypherpunk Technologies Stock Up 12.6%

Cypherpunk Technologies stock opened at $0.79 on Wednesday. The company has a fifty day simple moving average of $0.77 and a 200-day simple moving average of $0.86. The firm has a market capitalization of $32.89 million, a price-to-earnings ratio of 11.34 and a beta of -0.16. Cypherpunk Technologies has a 52-week low of $0.22 and a 52-week high of $3.70.

Institutional Trading of Cypherpunk Technologies

Several institutional investors and hedge funds have recently added to or reduced their stakes in CYPH. Millennium Management LLC purchased a new position in shares of Cypherpunk Technologies in the 4th quarter valued at approximately $37,000. LPL Financial LLC acquired a new position in shares of Cypherpunk Technologies in the fourth quarter valued at approximately $38,000. HighTower Advisors LLC purchased a new stake in shares of Cypherpunk Technologies during the fourth quarter worth approximately $59,000. State Street Corp purchased a new stake in shares of Cypherpunk Technologies during the fourth quarter worth approximately $163,000. Finally, Geode Capital Management LLC acquired a new stake in shares of Cypherpunk Technologies during the fourth quarter worth $615,000. 30.46% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

A number of equities analysts recently weighed in on CYPH shares. Wall Street Zen upgraded shares of Cypherpunk Technologies from a “sell” rating to a “hold” rating in a research report on Tuesday, November 25th. Weiss Ratings reiterated a “sell (e+)” rating on shares of Cypherpunk Technologies in a report on Thursday, January 22nd. One research analyst has rated the stock with a Hold rating and one has assigned a Sell rating to the stock. According to MarketBeat.com, the company presently has an average rating of “Reduce”.

Cypherpunk Technologies Company Profile

Cypherpunk Technologies Inc, previously known as Leap Therapeutics, Inc, is a company developing novel therapies for patients with cancer and implementing a digital asset treasury strategy focused on Zcash. The company’s research platform centers on modulating the tumor microenvironment to enhance anti-tumor immune responses. Cypherpunk’s proprietary pipeline includes DKN-01, a monoclonal antibody designed to neutralize Dickkopf-1 (DKK1), a protein implicated in tumor growth and immune evasion.

DKN-01 is being evaluated both as a monotherapy and in combination with checkpoint inhibitors such as pembrolizumab across multiple solid tumor indications, including gastroesophageal, pancreatic and other advanced malignancies.